Pierre Hirsch

3.0k total citations
39 papers, 568 citations indexed

About

Pierre Hirsch is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Pierre Hirsch has authored 39 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 18 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Pierre Hirsch's work include Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Pierre Hirsch is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Pierre Hirsch collaborates with scholars based in France, United States and Türkiye. Pierre Hirsch's co-authors include François Delhommeau, Ollivier Legrand, Christophe Marzac, Simona Lapusan, Ruoping Tang, Jean‐Pierre Marie, Francesca Fava, Fanny Fava, Mohamad Mohty and A. Mékinian and has published in prestigious journals such as Nature Communications, Blood and International Journal of Molecular Sciences.

In The Last Decade

Pierre Hirsch

36 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Hirsch France 15 294 158 153 143 100 39 568
Kátia Bórgia Barbosa Pagnano Brazil 13 384 1.3× 290 1.8× 163 1.1× 118 0.8× 133 1.3× 90 569
Salman Fazal United States 12 394 1.3× 320 2.0× 192 1.3× 140 1.0× 121 1.2× 51 653
Jo-Anne Vergilio United States 7 198 0.7× 166 1.1× 147 1.0× 64 0.4× 35 0.3× 8 457
Maitrayee Goswami United States 16 506 1.7× 304 1.9× 191 1.2× 165 1.2× 31 0.3× 31 735
Caterina Matteucci Italy 15 306 1.0× 117 0.7× 219 1.4× 65 0.5× 34 0.3× 49 604
Cristina Rosanda Italy 12 193 0.7× 70 0.4× 194 1.3× 59 0.4× 73 0.7× 38 479
Caner Saygin United States 11 150 0.5× 63 0.4× 104 0.7× 174 1.2× 31 0.3× 29 449
Ryan J. Mattison United States 12 273 0.9× 159 1.0× 238 1.6× 111 0.8× 24 0.2× 58 518
Bianca F. Goemans Netherlands 10 419 1.4× 115 0.7× 200 1.3× 85 0.6× 19 0.2× 34 563
Nicolas Duployez France 17 621 2.1× 303 1.9× 375 2.5× 79 0.6× 135 1.4× 67 950

Countries citing papers authored by Pierre Hirsch

Since Specialization
Citations

This map shows the geographic impact of Pierre Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Hirsch more than expected).

Fields of papers citing papers by Pierre Hirsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Hirsch. The network helps show where Pierre Hirsch may publish in the future.

Co-authorship network of co-authors of Pierre Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Hirsch. A scholar is included among the top collaborators of Pierre Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Hirsch. Pierre Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lin‐Pierre, Vincent Jachiet, Olivier Kosmider, et al.. (2025). Very long-term remission with azacitidine in VEXAS syndrome. Haematologica. 110(6). 1432–1435. 1 indexed citations
2.
Picou, Frédéric, Christelle Debeissat, Nathalie Gallay, et al.. (2022). Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia. Cancer Gene Therapy. 29(8-9). 1263–1275. 6 indexed citations
3.
Guermouche, Hélène, Fabrizia Favale, Maxime Battistella, et al.. (2021). Dominance of an <i>UBA1</i> mutant clone over a <i>CALR</i> mutant clone: from essential thrombocytemia to VEXAS.. Haematologica. 106(12). 3245–3248. 20 indexed citations
4.
Passet, Marie, C. Lepelletier, Marie‐Dominique Vignon‐Pennamen, et al.. (2020). Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils. Journal of Investigative Dermatology. 140(9). 1873–1876.e5. 24 indexed citations
5.
Guermouche, Hélène, Nathalie Gallay, Caroline Deswarte, et al.. (2020). High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers. Blood Advances. 4(15). 3550–3557. 33 indexed citations
6.
7.
Chasset, François, Philippe Moguelet, Noémie Abisror, et al.. (2019). Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation. Haematologica. 104(11). e530–e533. 15 indexed citations
8.
Labopin, Myriam, Anne‐Claire Mamez, Simona Lapusan, et al.. (2019). Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia. Bone Marrow Transplantation. 55(2). 452–460. 11 indexed citations
9.
Bonnet, Catherine, Frédéric Mazenc, Jean Clairambault, et al.. (2018). Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues. Journal of Theoretical Biology. 449. 103–123. 8 indexed citations
10.
Lehmann‐Che, Jacqueline, Cécile Bally, Éric Letouzé, et al.. (2018). Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia. Nature Communications. 9(1). 2047–2047. 33 indexed citations
11.
12.
Hirsch, Pierre, Ruoping Tang, Nasséra Abermil, et al.. (2017). Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia. Haematologica. 102(7). 1227–1237. 38 indexed citations
13.
Sarkozy, Clémentine, Thierry Jo Molina, Hervé Ghesquières, et al.. (2016). Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association. Haematologica. 102(1). 150–159. 33 indexed citations
14.
Bally, Cécile, Jacqueline Lehmann‐Che, Bruno Cassinat, et al.. (2016). Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia. Blood. 128(22). 2892–2892. 1 indexed citations
15.
Kempf, Emmanuelle, Pierre Hirsch, Myriam Labopin, et al.. (2014). Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia. Leukemia Research. 38(12). 1425–1429. 11 indexed citations
16.
Hirsch, Pierre, Christophe Marzac, Ruoping Tang, et al.. (2014). Acute myeloid leukemia in patients older than 75: prognostic impact ofFLT3-ITDandNPM1mutations. Leukemia & lymphoma. 56(1). 147–150. 7 indexed citations
17.
Hirsch, Pierre, Mathieu Leclerc, M. Rybojad, et al.. (2012). Female Genital Chronic Graft-Versus-Host Disease. Transplantation. 93(12). 1265–1269. 39 indexed citations
18.
Hirsch, Pierre, Christophe Marzac, Jean‐Yves Perrot, et al.. (2011). Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC. Haematologica. 97(2). 241–245. 20 indexed citations
19.
Haïat, Stéphanie, Zora Marjanovic, Simona Lapusan, et al.. (2010). Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol. Leukemia Research. 35(1). 66–72. 22 indexed citations
20.
Tang, Ruoping, Pierre Hirsch, Fanny Fava, et al.. (2009). High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. Blood. 114(14). 2993–3000. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kátia Bórgia Barbosa Pagnano Breakdown of academic impact, for papers by Salman Fazal Breakdown of academic impact, for papers by Jo-Anne Vergilio Breakdown of academic impact, for papers by Maitrayee Goswami Breakdown of academic impact, for papers by Caterina Matteucci Breakdown of academic impact, for papers by Cristina Rosanda Breakdown of academic impact, for papers by Caner Saygin Breakdown of academic impact, for papers by Ryan J. Mattison Breakdown of academic impact, for papers by Bianca F. Goemans Breakdown of academic impact, for papers by Nicolas Duployez
Rankless by CCL
2026